The U.S. Food and Drug Administration (FDA) has recently approved the PARI eRapid electronic nebulizer as the first of its kind that's suitable for giving Pulmozyme treatments to people with Cystic Fibrosis.
An Efficient Treatment Method
Pulmozyme is a drug manufactured by Genentech, which is frequently prescribed to Cystic Fibrosis patients. It helps thin mucous buildup in the lungs and can reduce the risk of respiratory infections.
Many patients need several Pulmozyme treatments per day, and the eRapid nebulizer system can help them receive the medication more efficiently. Normally, Pulmozyme treatments take an average of 6-8 minutes. However, when patients get the medicine via the eRapid, that timeframe is shortened to just 2-3 minutes. Because many patients are on daily Pulmozyme regimens for years, those saved minutes go a long way, and could help encourage adherence to doctors’ orders.
Patient Preferences and Satisfying Outcomes
The eRapid system has already been used for years in Europe with successful results, and was distributed under the eFlow Rapid brand name. However, PARI decided to introduce it to the United States after input from the Cystic Fibrosis Foundation indicated an electronic nebulizer marketed for general use could improve patient compliance.
In a clinical trial involving Pulmozyme treatments delivered with the eRapid, pediatric patients had a 10:1 preference for the device, while that choice was echoed as a 20:1 preference among adults. Users appreciated the quick treatment times and small, easily portable size of the eRapid. Patients in the study were also generally more satisfied with treatments when using the eRapid.
To read more about the study, click here. Nebology is the first online retailer to sell the eRapid electronic nebulizer system. You can purchase it after obtaining a prescription from your physician or pulmonologist.
At Nebology, we believe it’s important for our customers to be able to make the best choices for their health. That’s why we’re excited about being the first online retailer to sell the eRapid nebulizer system.
It can reduce treatment times by nearly a third, and is designed to produce consistently sized particles for reliable performance and effective treatments. This travel-friendly and easy-to-use system is available from us at a significant discount, and offered by prescription only. Contact our customer service team for more details, or read more about the eRapid system here.
If you’re ready to begin using a dependable aerosol therapy system that supports your interest in environmental sustainability, PARI Vios ‘Go Green’ compressors are now available to purchase. They’ll easily fit in with your eco-conscious lifestyle goals.
New for This Year
Ever since the original Vios systems were released in 2010, PARI has enjoyed a consistent reputation for producing reliable compressor systems and accessories that are depended upon for daily use by patients, and preferred by healthcare providers in clinical settings.
That strong commitment to high-quality products remains the same, but the items in the Vios 'Go Green' line are new designs. They are appropriate for both adults and kids, and available in either the LC Plus or LC Sprint configuration.